Stage IIIB Breast Cancer AJCC v7 Active Not Recruiting Phase 1 Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0092287 (Stage IIIB Breast Cancer AJCC v7)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02152943Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive PatientsTreatment